Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ishihara Sangyo Kaisha ("ISK") is a diversified Japanese chemical manufacturer with global operations. Its business spans inorganic chemicals (notably titanium dioxide), organic chemicals, agrochemicals, animal health products, pharmaceuticals—including active pharmaceutical ingredients—and custom synthesis services. In healthcare/life sciences, it acts as an API supplier and contract manufacturer rather than a drug developer with its own clinical pipeline. The company has over a century of history and maintains significant R&D capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ishihara Sangyo Kaisha.